SK44299A3 - Colonic delivery of weak acid drugs - Google Patents

Colonic delivery of weak acid drugs Download PDF

Info

Publication number
SK44299A3
SK44299A3 SK442-99A SK44299A SK44299A3 SK 44299 A3 SK44299 A3 SK 44299A3 SK 44299 A SK44299 A SK 44299A SK 44299 A3 SK44299 A3 SK 44299A3
Authority
SK
Slovakia
Prior art keywords
composition
drug
salt
ridogrel
composition according
Prior art date
Application number
SK442-99A
Other languages
English (en)
Slovak (sk)
Inventor
Peter James Watts
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of SK44299A3 publication Critical patent/SK44299A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK442-99A 1996-10-04 1997-10-06 Colonic delivery of weak acid drugs SK44299A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9620709.7A GB9620709D0 (en) 1996-10-04 1996-10-04 Colonic delivery of weak acid drugs
PCT/GB1997/002726 WO1998015265A1 (en) 1996-10-04 1997-10-06 Colonic delivery of weak acid drugs

Publications (1)

Publication Number Publication Date
SK44299A3 true SK44299A3 (en) 2000-05-16

Family

ID=10800944

Family Applications (1)

Application Number Title Priority Date Filing Date
SK442-99A SK44299A3 (en) 1996-10-04 1997-10-06 Colonic delivery of weak acid drugs

Country Status (17)

Country Link
US (1) US20020015729A1 (zh)
EP (1) EP0956006A1 (zh)
JP (1) JP2001501642A (zh)
KR (1) KR20000048939A (zh)
CN (1) CN1232386A (zh)
AU (1) AU732210B2 (zh)
BR (1) BR9712163A (zh)
CA (1) CA2264637A1 (zh)
CZ (1) CZ118899A3 (zh)
GB (2) GB9620709D0 (zh)
HU (1) HUP9904320A3 (zh)
IL (1) IL129185A0 (zh)
NO (1) NO991519L (zh)
NZ (1) NZ334313A (zh)
PL (1) PL332555A1 (zh)
SK (1) SK44299A3 (zh)
WO (1) WO1998015265A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2350307T3 (es) 2000-09-06 2011-01-20 Mitsubishi Tanabe Pharma Corporation Preparaciones granulares para administración oral.
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
MXPA05010636A (es) * 2003-04-04 2005-12-12 Pharmacia Corp Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
FR3008281B1 (fr) * 2013-07-15 2015-07-31 Chantelle Coque de soutien-gorge et son procede de fabrication
US20210113479A1 (en) * 2018-05-03 2021-04-22 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211777A (en) * 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders
US5843482A (en) * 1990-07-20 1998-12-01 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
EP0613373B1 (en) * 1991-11-22 2000-08-02 THE PROCTER & GAMBLE PHARMACEUTICALS, INC. Risedronate delayed-release compositions
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
JP2916978B2 (ja) * 1993-08-25 1999-07-05 エスエス製薬株式会社 放出開始制御型製剤
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
JPH10511097A (ja) * 1995-03-28 1998-10-27 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用

Also Published As

Publication number Publication date
KR20000048939A (ko) 2000-07-25
NO991519D0 (no) 1999-03-29
EP0956006A1 (en) 1999-11-17
US20020015729A1 (en) 2002-02-07
AU732210B2 (en) 2001-04-12
CZ118899A3 (cs) 1999-07-14
BR9712163A (pt) 2000-01-18
JP2001501642A (ja) 2001-02-06
GB9620709D0 (en) 1996-11-20
CA2264637A1 (en) 1998-04-16
HUP9904320A2 (hu) 2000-06-28
GB9907298D0 (en) 1999-05-26
CN1232386A (zh) 1999-10-20
GB2333042A (en) 1999-07-14
NZ334313A (en) 2000-09-29
AU4565597A (en) 1998-05-05
NO991519L (no) 1999-03-29
HUP9904320A3 (en) 2000-08-28
WO1998015265A1 (en) 1998-04-16
GB2333042B (en) 2000-10-18
PL332555A1 (en) 1999-09-13
IL129185A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
JP5808670B2 (ja) 弱塩基性薬物を含む組成物及び徐放性剤形
CA2337046C (en) Sustained release pharmaceutical preparation
JP2002525314A (ja) Ｈｐｍｃカプセルを使用する腸及び結腸への送達
SK285152B6 (sk) Enterický potiahnutý farmaceutický prostriedok a spôsob jeho prípravy
CZ300497B6 (cs) Farmaceutický prostredek, jeho sferonizované jádro a zpusob prípravy jader a farmaceutického prostredku
EP1622601B1 (en) Pharmaceutical compositions
US20020031550A1 (en) Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
CA2304135C (en) Medicament formulation with a controlled release of an active agent
AU724086B2 (en) Controlled release dosage form of (R-(Z))-alpha- (methoxyimino)-alpha-(1-azabicyclo(2.2.2)oct-3-yl) acetonitrile monohydrochloride
JP4771956B2 (ja) バイオアベイラビリティーエンハンサを含む第四級アンモニウム化合物の組成物
SK44299A3 (en) Colonic delivery of weak acid drugs
US20230181479A1 (en) Polymer based formulation for release of drugs and bioactives at specific git sites
AU627335B2 (en) Aspirin granules with gastroprotectant coating
MXPA99003093A (en) Colonic delivery of weak acid drugs
MXPA06004018A (es) Composiciones de amonio cuaternario que contienen mejoradores de biodisponibilidad
MXPA99002404A (en) Controlled release dosage form of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2. 2]oct-3-yl)acetonitrile monohydrochloride